Nanoparticle Vaccines For Coronaviruses Read more about Nanoparticle Vaccines For Coronaviruses US Application 63/022,214Filed on 2020-05-08
NEWCASTLE DISEASE VIRUS-LIKE PARTICLE DISPLAYING PREFUSION-STABILIZED SARS-COV-2 SPIKE AND ITS USE Read more about NEWCASTLE DISEASE VIRUS-LIKE PARTICLE DISPLAYING PREFUSION-STABILIZED SARS-COV-2 SPIKE AND ITS USE US Application 63/140,250Filed on 2021-01-21
Novel Compositions Of Matter Comprising Stabilized Coronavirus Antigens And Their Use Read more about Novel Compositions Of Matter Comprising Stabilized Coronavirus Antigens And Their Use US Application 63/200,194Filed on 2021-02-19
REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE Read more about REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE US Application 63/138,221Filed on 2021-01-15
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens US Application 62/986,295Filed on 2020-03-06
Antibodies Targeting The Spike Protein Of Coronaviruses Read more about Antibodies Targeting The Spike Protein Of Coronaviruses US Application 63/147,419Filed on 2021-02-09
Human Monoclonal Antibodies Targeting SARS-CoV-2 Read more about Human Monoclonal Antibodies Targeting SARS-CoV-2 US Application 63/127,077Filed on 2020-12-17
DNA VECTOR AND USES THEREOF FOR DETECTING HIV AND SIV Read more about DNA VECTOR AND USES THEREOF FOR DETECTING HIV AND SIV US Application 63/128,392Filed on 2020-12-21
NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF Read more about NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF US Application 63/115,729Filed on 2020-11-19
Recombinant Chimeric Bovine/Human Parainfluenza Virus 3 Expressing SARS-COV-2 Spike Protein and Its Use Read more about Recombinant Chimeric Bovine/Human Parainfluenza Virus 3 Expressing SARS-COV-2 Spike Protein and Its Use US Application 63/180,534Filed on 2021-04-27